GALT EPS Estimates
Galectin Therapeutics Inc.
$3.94
+$0.30(+8.24%)
35
Overall
40
Value
40
Tech
26
Quality
Market Cap
$398.13M
Volume
156.41K
52W Range
$2.03 - $7.13
Target Price
$11.00
GALT EPS estimates: the consensus estimate for Galectin Therapeutics Inc.'s current fiscal year is -$0.30 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
GALT EPS Estimates
- EPS estimate, current quarter
- $-0.05
- EPS estimate, next quarter
- $-0.05
- EPS estimate, current year
- $-0.30
- EPS estimate, next year
- $-0.23
- EPS growth, 3-year
- +9.61%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.48 |
| 2024 | $-0.76 |
| 2023 | $-0.74 |
| 2022 | $-0.65 |
| 2021 | $-0.52 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GALT | $3.94 | +8.2% | 156.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Galectin Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW